Source:http://linkedlifedata.com/resource/pubmed/id/10070038
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
1999-4-15
|
pubmed:abstractText |
Central neuropeptides play important roles in many instances of physiological and pathophysiological regulation mediated through the autonomic nervous system. In regard to the hepatobiliary system, several neuropeptides act in the brain to regulate bile secretion, hepatic blood flow, and hepatic proliferation. Stressors and sympathetic nerve activation are reported to exacerbate experimental liver injury. Some stressors are known to stimulate corticotropin-releasing factor (CRF) synthesis in the central nervous system and induce activation of sympathetic nerves in animal models. The effect of intracisternal CRF on carbon tetrachloride (CCl4)-induced acute liver injury was examined in rats. Intracisternal injection of CRF dose dependently enhanced elevation of the serum alanine aminotransferase (ALT) level induced by CCl4. Elevations of serum aspartate aminotransferase, alkaline phosphatase, and total bilirubin levels by CCl4 were also enhanced by intracisternal CRF injection. Intracisternal injection of CRF also aggravated CCl4-induced hepatic histological changes. Intracisternal CRF injection alone did not modify the serum ALT level. Intravenous administration of CRF did not influence CCl4-induced acute liver injury. The aggravating effect of central CRF on CCl4-induced acute liver injury was abolished by denervation of hepatic plexus with phenol and by denervation of noradrenergic fibers with 6-hydroxydopamine treatment but not by hepatic branch vagotomy or atropine treatment. These results suggest that CRF acts in the brain to exacerbate acute liver injury through the sympathetic-noradrenergic pathways.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G622-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10070038-Acute Disease,
pubmed-meshheading:10070038-Animals,
pubmed-meshheading:10070038-Atropine,
pubmed-meshheading:10070038-Brain,
pubmed-meshheading:10070038-Carbon Tetrachloride,
pubmed-meshheading:10070038-Corticotropin-Releasing Hormone,
pubmed-meshheading:10070038-Denervation,
pubmed-meshheading:10070038-Drug Synergism,
pubmed-meshheading:10070038-Drug-Induced Liver Injury,
pubmed-meshheading:10070038-Injections, Intraventricular,
pubmed-meshheading:10070038-Liver,
pubmed-meshheading:10070038-Liver Diseases,
pubmed-meshheading:10070038-Male,
pubmed-meshheading:10070038-Oxidopamine,
pubmed-meshheading:10070038-Rats,
pubmed-meshheading:10070038-Rats, Wistar,
pubmed-meshheading:10070038-Vagotomy
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effect of central corticotropin-releasing factor on carbon tetrachloride-induced acute liver injury in rats.
|
pubmed:affiliation |
Second Department of Medicine, Asahikawa Medical College, Asahikawa 078, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|